A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma

NCT02472756 · clinicaltrials.gov ↗

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Follicular

Interventions

DRUG: Chemotherapy
DRUG: Rituximab

Sponsor

Hoffmann-La Roche